StonvexLoading…
StonvexStonvexStonvexCore line items from ABCB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-27 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $330.25M | $351.77M | $1.39B | $1.04B | $681.42M |
Operating Income | Not available | $140.72M | $533.76M | $392.67M | $255.63M |
Net Income | Not available | $110.49M | $412.15M | $303.80M | $197.77M |
EPS (Diluted) | $1.70 | $1.63 | $6.00 | $4.41 | $2.87 |
Total Assets | Not available | $28.11B | $27.52B | $27.10B | $26.68B |
Total Liabilities | Not available | $24.03B | $23.44B | $23.08B | $22.76B |
Cash & Equivalents | Not available | $1.33B | $1.09B | $1.04B | $1.17B |
Free Cash Flow OCF − CapEx | Not available | $249.41M | $369.64M | $268.41M | $167.89M |
Shares Outstanding | Not available | 67.77M | 68.71M | 68.83M | 68.91M |